Stay updated on Dupilumab in Prurigo Nodularis: Clinical Trial
Sign up to get notified when there's something new on the Dupilumab in Prurigo Nodularis: Clinical Trial page.

Latest updates to the Dupilumab in Prurigo Nodularis: Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedNew publication citation added: Stander et al. Dupilumab Improves Prurigo Activity and Severity in Patients with Prurigo Nodularis: A Post Hoc Analysis of Pooled Results from the PRIME and PRIME2 Trials (Dermatol Ther, 2026).SummaryDifference0.0%

- Check21 days agoNo Change Detected
- Check29 days agoChange Detected- Updated site revision from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check43 days agoChange DetectedRevision: v3.4.3 was added and Revision: v3.4.2 was removed from the page. No study content is affected.SummaryDifference0.0%

- Check64 days agoChange DetectedRevision updated to v3.4.2 replacing v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check72 days agoChange DetectedAdded a 2026 Am J Clin Dermatol publication entry for dupilumab in prurigo nodularis and updated it to Revision: v3.4.1; removed the previous Online ahead of print entry for the same article (Revision: v3.4.0).SummaryDifference0.1%

- Check87 days agoChange DetectedThe page now displays a Last Update Posted timestamp, and the label 'Last Update Posted (Estimated)' has been removed to clarify update timing. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Dupilumab in Prurigo Nodularis: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dupilumab in Prurigo Nodularis: Clinical Trial page.